Insider Trading & Executive Data
Start Free Trial
14 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Focus Universal Inc. (FCUV) is a small‑cap Technology company in the Scientific & Technical Instruments industry that builds an IoT universal smart instrumentation platform (USIP) and a portable device called the Ubiquitor, alongside sensor modules, PLC and ultra‑narrowband 5G+ comms, traditional measurement meters and an AI‑enabled SEC reporting SaaS (via subsidiary Lusher). Operations combine U.S. R&D and final assembly with China‑based manufacturing/engineering support; revenue channels include wholesale distribution (notably Hydrofarm), direct B2B, and e‑commerce, with product commercialization and OEM/licensing as growth levers. Recent filings show modest revenues, rising R&D and G&A spend, a Nasdaq listing (Sept 2024), meaningful IP holdings (28 patents/pending), and a going‑concern qualification driven by recurring losses and tight cash.
Given the company’s early commercialization stage, heavy R&D intensity ($1.38M in 2024; tooling/R&D leaps in 2025) and cash constraints, compensation is shifting toward equity‑linked pay and stock‑based awards to conserve cash and align management with long‑term product milestones (the 10‑Q notes higher officer/director stock compensation: $125k vs $55k prior). Typical pay design for small tech/scientific instrument firms applies lower base salaries with bonuses tied to commercialization milestones (Ubiquitor production, PLC chip development), IP prosecution milestones and revenue/OEM contract wins; Focus’s increased professional/legal fees and litigation exposure also suggest pay may include retention grants to key technical staff. The Nasdaq listing and patent portfolio create governance pressure for a formal compensation committee and clearer disclosure of equity plans; continued financing needs make equity dilution a likely component of future compensation.
Insiders at Focus Universal are likely to trade (or be restricted from trading) around discrete liquidity and milestone events: financings (e.g., Alumni Capital purchase), Nasdaq listing, tooling/mold completion, product launches, trade shows (CES), and material property sales that affect reported results. Watch for increased open‑market sales following capital raises or when cash is tight (working capital declined to ~$708k and cash was $1.15M at 6/30/25), and for insider purchases or 10b5‑1 plans that signal confidence in commercialization timelines. Regulatory drivers include Section 16 reporting obligations, Nasdaq disclosure/compliance rules and typical blackout windows around earnings and financings; given litigation and going‑concern risk, any rapid or clustered insider transactions merit scrutiny for information asymmetry and should be cross‑checked against Form 4s, lockup terms from financings, and adoption of trading plans.